$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
慢性乙肝患者肝纤维化的临床预测指标
2025-10-19 11:44:20
Check Details
乙肝替诺福韦停药研究
2025-10-19 11:44:20
Check Details
乙肝治疗:干扰素是否还有一席之地?
2025-10-19 11:44:20
Check Details
乙型肝炎患者禁食是否安全?
2025-10-19 11:44:20
Check Details
乙肝替诺福韦治疗改善生存率
2025-10-19 11:44:20
Check Details
乙肝母婴传播风险随病毒载量增加
2025-10-19 11:44:20
Check Details
乙肝新联合疗法初见成效
2025-10-19 11:44:20
Check Details
肝移植后乙肝防治:专家问答
2025-10-19 11:44:20
Check Details
慢性乙肝患者产后肝炎发作特点及预测因素
2025-10-19 11:44:20
Check Details
3亿乙型肝炎患者,但只有20%接受治疗
2025-10-19 11:44:20
Check Details
乙肝药物对母婴传播影响不大
2025-10-19 11:44:20
Check Details
乙型肝炎患者禁食是否安全
2025-10-19 11:44:20
Check Details
1
2
...
5687
5688
5689
5690
5691
5692
5693
...
10242
10243
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
How to Take Selinexor: Dosing, Food, and Safety
2
FDA Approves Nelkarmi for ALK-TKI-Resistant NSCLC
3
FDA Approves Lembaz: First Therapy Shown to Extend Survival in Infantile-Onset NPC
4
Klygefa FDA Approval: Weekly Subcutaneous C5 Inhibition for AChR-Positive gMG
5
What Is Pralsetinib? RET-Positive Lung and Thyroid Cancer Explained
6
Sotorasib Diarrhea in NSCLC: Grading, Loperamide and Dose Adjustment
7
Avatrombopag vs Eltrombopag in ITP: Onset, Dosing Rules and Pre‑Procedure Use
8
Gilteritinib and Differentiation Syndrome in AML: Recognition, Emergency Management and Monitoring
9
Pralsetinib and Hypertension in NSCLC: Risks, Monitoring and Management
10
Tucatinib Overview: HER2-Positive Breast Cancer and RAS Wild-Type Colorectal Cancer Dosing, Brain Metastases Data and Safety
11
FDA Approves Durvalumab Plus Enfortumab Vedotin for Perioperative Treatment of Cisplatin-Ineligible Muscle-Invasive Bladder Cancer
12
Bepirovirsen (Hibsago) Prescribing Information: Indications, Boxed Warnings, Dose Adjustment and Monitoring